TipRanks
Go Ultimate55% OFF

Jasbir Seehra Insider Profile

4 Followers

Jasbir Seehra, CEO, Director at Keros Therapeutics, holds 440.71K shares in Keros Therapeutics (Ticker: KROS), holds ― shares in Eloxx Pharmaceuticals (Ticker: ELOX).

Jasbir Seehra's Trading History

KROS
Keros Therapeutics
Apr 06, 2026CEO, DirectorUninformative Buy16.50K$4.87M
ELOX
Eloxx Pharmaceuticals
―Director――

You May Also Like

Jasbir Seehra insider profile FAQ

What is the percentage of profitable transactions made by Jasbir Seehra?
The percentage of profitable transactions made by Jasbir Seehra is 100%.
What is the average return per transaction made by Jasbir Seehra?
The average return per transaction made by Jasbir Seehra is 103.70%.
What stocks does Jasbir Seehra hold?
Jasbir Seehra holds: KROS, ELOX stocks.
What was Jasbir Seehra’s latest transaction?
Jasbir Seehra’s latest transaction was an Uninformative Buy of $16.50K.
What was Jasbir Seehra's most profitable transaction?
Jasbir Seehra’s most profitable transaction was an Informative Buy of KROS stock on April 13, 2020. The return on the trade was 175.70%.
What is Jasbir Seehra's role in Keros Therapeutics?
Jasbir Seehra's role in Keros Therapeutics is CEO, Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.